RedHill Biopharma Ltd. (RDHL) is priced at $7.52 after the most recent trading session. At the very opening of the session, the stock price was $7.40 and reached a high price of $7.79, prior to closing the session it reached the value of $8.71. The stock touched a low price of $6.85.
Recently in News on January 12, 2021, RedHill Biopharma Increases Previously Announced Bought Deal to $25 Million. RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, today announced that due to demand, the underwriter has agreed to increase the size of the previously announced offering and purchase on a firm commitment basis 3,188,776 American Depositary Shares (ADSs) of the Company, at a price to the public of $7.84 per ADS, less underwriting discounts and commissions. Each ADS represents ten ordinary shares, par value NIS 0.01 per share, of the Company. The closing of the offering is expected to occur on or about January 14, 2021, subject to satisfaction of customary closing conditions. You can read further details here
Gold bugs are shouting from the rooftops in excitement, but that doesn’t mean you rush out and just buy any gold stock…That’s why we laid out The 2021 Ultimate Gold Portfolio – to dissect the treasure from the trash.
RedHill Biopharma Ltd. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $8.77 on 01/11/21, with the lowest value was $6.85 for the same time period, recorded on 01/12/21.
RedHill Biopharma Ltd. (RDHL) full year performance was 24.92%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, RedHill Biopharma Ltd. shares are logging -33.74% during the 52-week period from high price, and 130.53% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $3.26 and $11.35.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 2674537 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the RedHill Biopharma Ltd. (RDHL) recorded performance in the market was -6.93%, having the revenues showcasing -24.50% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 287.64M, as it employees total of 155 workers.
Analysts verdict on RedHill Biopharma Ltd. (RDHL)
During the last month, 0 analysts gave the RedHill Biopharma Ltd. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 8.98, with a change in the price was noted -0.85. In a similar fashion, RedHill Biopharma Ltd. posted a movement of -10.16% for the period of last 100 days, recording 335,514 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for RDHL is recording 2.99 at the time of this writing. In addition, long term Debt to Equity ratio is set at 2.94.
RedHill Biopharma Ltd. (RDHL): Technical Analysis
Raw Stochastic average of RedHill Biopharma Ltd. in the period of last 50 days is set at 21.34%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 21.34%. In the last 20 days, the company’s Stochastic %K was 25.46% and its Stochastic %D was recorded 24.26%.
Let’s take a glance in the erstwhile performances of RedHill Biopharma Ltd., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -6.93%. Additionally, trading for the stock in the period of the last six months notably improved by 17.87%, alongside a boost of 24.92% for the period of the last 12 months. The shares increased approximately by -8.07% in the 7-day charts and went up by -9.83% in the period of the last 30 days. Common stock shares were lifted by -24.50% during last recorded quarter.